Skip to content

A COMPARASON OF EFFECTS OF KETAMINE-DEXMEDETOMIDINE VERSUS FENTANYL-PROPOFOL IN PATIENTS UNDERGOING CARDIAC SURGERY FOR MYOCARDIAL PROTECTION

A RANDOMISED COMPARATIVE STUDY FOR CARDIAC PRECONDITIONING EFFECT OF KETAMINE-DEXMEDETOMIDINE VERSUS FENTANYL-PROPOFOL IN PATIENTS UNDERGOING CARDIAC SURGERY IN THE DEPARTMENT OF ANAESTHESIA. - NIL

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/07/071613
Enrollment
110
Registered
2024-07-31
Start date
Unknown
Completion date
Unknown
Last updated
2024-08-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O- Medical and Surgical

Interventions

Intervention1: Group A- Ketamine-Dexmedetomidine: This group involves infusion of Ketamine and Dexmedetomidine that will be administered intra operatively for cardiac preconditioning of cardiac bio ma

Sponsors

SMS Medical College and Hospital
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Informed written consent for the study 2. All patients will be American Society of Anaesthesiologists physical status II-III. 3. Aged between 18 and 70 years. 4. Weight between 40 and 70 kg. 5. BMI less than 30. 6. New York Heart Association classification of cardiac function II-III, 7. Ejection fraction greater than 40%

Exclusion criteria

Exclusion criteria: 1. Patient should not part of any other study. 2. Non cooperative patient. 3. Patient with history of acute myocardial infarction. 4. Elevated levels of circulating cardiac troponin 5. History of endocrine, metabolic, neurological and psychotic disorder 6. History of previous unusual response to ketamine, dexmedotomidine, fentanyl, propofol

Design outcomes

Primary

MeasureTime frame
To assess and compare the Plasma cardiac troponin-I, CK-MB level, serum cortisol level in Ketamine-dexmedetomidine group and fentanyl-propofol groupTimepoint: Blood samples will be drawn before induction, 4 hours after aortic cross clamping and 24 hours after aortic cross clamping.

Secondary

MeasureTime frame
NIlTimepoint: NIL

Countries

India

Contacts

Public ContactDr Jaskaran Singh Marjara

SMS Medical College

dranjumsaiyed@gmail.com9214021930

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026